Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Shafer

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
The American Review of Respiratory Disease|December 1, 1989
Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDSR W Shafer, R Goldberg, M Sierra, et al.
Journal of Virological Methods|April 28, 2000
Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individualsR W Shafer, A Warford, M A Winters, et al.
Controlled Clinical Trials|April 18, 2001
ACTG (AIDS Clinical Trials Group) 384: a strategy trial comparing consecutive treatments for HIV-1L M Smeaton, V DeGruttola, G K Robbins, et al.
Annals of Internal Medicine|June 20, 1998
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patientsR W Shafer, M A Winters, S Palmer, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1995
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patientR W Shafer, S P Singh, C Larkin, et al.
The Journal of Infectious Diseases|August 1, 1996
Zidovudine resistance reverse transcriptase mutations during didanosine monotherapyR W Shafer, M A Winters, R M Jellinger, et al.
Medicine|November 1, 1991
Extrapulmonary tuberculosis in patients with human immunodeficiency virus infectionR W Shafer, D S Kim, J P Weiss, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitorsR W Shafer, M A Winters, A K Iversen, et al.
Journal of Virology|July 1, 1997
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in ZimbabweR W Shafer, J A Eisen, T C Merigan, et al.
Journal of Virology|June 11, 1999
Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitorsR W Shafer, P Hsu, A K Patick, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The American Review of Respiratory Disease|December 1, 1989
Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDSR W Shafer, R Goldberg, M Sierra, et al.
Journal of Virological Methods|April 28, 2000
Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individualsR W Shafer, A Warford, M A Winters, et al.
Controlled Clinical Trials|April 18, 2001
ACTG (AIDS Clinical Trials Group) 384: a strategy trial comparing consecutive treatments for HIV-1L M Smeaton, V DeGruttola, G K Robbins, et al.
Annals of Internal Medicine|June 20, 1998
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patientsR W Shafer, M A Winters, S Palmer, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1995
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patientR W Shafer, S P Singh, C Larkin, et al.
The Journal of Infectious Diseases|August 1, 1996
Zidovudine resistance reverse transcriptase mutations during didanosine monotherapyR W Shafer, M A Winters, R M Jellinger, et al.
Medicine|November 1, 1991
Extrapulmonary tuberculosis in patients with human immunodeficiency virus infectionR W Shafer, D S Kim, J P Weiss, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitorsR W Shafer, M A Winters, A K Iversen, et al.
Journal of Virology|July 1, 1997
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in ZimbabweR W Shafer, J A Eisen, T C Merigan, et al.
Journal of Virology|June 11, 1999
Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitorsR W Shafer, P Hsu, A K Patick, et al.
Pageof 7